Navigation Links
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
Date:10/29/2013

ALISO VIEJO, Calif., Oct. 29, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced preliminary financial information (unaudited) for the year ended September 30, 2013, in anticipation of the company's Investor Relations Day in New York City.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

Based on preliminary financial information for the fiscal year-ended September 30, 2013, Avanir estimates:

  • Total gross revenues of approximately $95.9 million (Non-GAAP)
  • Total net revenues in the range of approximately $75.3 million to $76.3 million
  • Total operating expenses of approximately $116.0 million, excluding cost of product sales of approximately $4.0 million, non-cash items such as share-based compensation of approximately $5.8 million, and depreciation and amortization of long-lived assets of approximately $800,000 and the one-time upfront payment to OptiNose of $20.0 million (Non-GAAP)
  • Cash, cash equivalents and investments in securities totaling approximately $57.5 million, including cash and cash equivalents of approximately $55.3 million and restricted investments in securities of approximately $2.2 million

"We are delighted with the progress of our NUEDEXTA PBA commercial business this year," said Keith Katkin, president and CEO of Avanir. "In addition, the R&D team has made great progress with our pipeline. We now have three active phase II studies of AVP-923 including MS neuropathic pain, Alzheimer's agitation, and the recently announced levodopa-induced dyskinesias in Parkinson's disease.  We continue to expect top-line data from our PRIME study in MS neuropathic pain
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
2. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
3. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
4. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
5. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
6. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
7. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
8. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
9. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
10. Avanir Pharmaceuticals to Participate in Two Conferences in August
11. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... , RIVIERA BEACH, Fla., Dec. 14 Perry Baromedical, international ... launch of the Sigma Elite, with extended patient data capture ... on each monoplace chamber model currently available ( www.perrybaromedical.com ) ... "Smart Hyperbaric System" includes: , Data Capture Via Computerized ...
... Dec. 14 Sword Diagnostics, Inc. is pleased to ... has issued patent number 7,599,057 titled "Method and Apparatus ... the company. The patent covers the core technology which ... this patent supports the underlying strategy as we move ...
Cached Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2
(Date:11/27/2014)... DressVe , the well-known trendy young women’s clothing retailer, has ... Nov. 29 – Dec. 3 2014. In the special offer, ... 90% off. In addition, free delivery is provided for the ... , Dresses that combine trendy styles and high quality ... and figure. The designers of DressVe.com know this point very ...
(Date:11/27/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... , Firstly, the report provides a basic overview of ... Then, the report explores the international and Chinese major ...
(Date:11/27/2014)... November 28, 2014 The American Society for ... social media campaign in honor of World AIDS Day 2014. ... tested. Find a cure.” icon and infographic designed to generate ... getting tested for HIV. , ASCP has asked members to ... “Give a minute. Get Tested. Find a cure.” icon and ...
(Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
(Date:11/27/2014)... 2014 In a world enveloped ... sleep has lessened, and due to the intrusion ... of sleep has eroded. According to Web MD, ... job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high ... an incalculable amount, leading not only to dissatisfied ...
Breaking Medicine News(10 mins):Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... of people are disappointed that the condom has not served ... sex, which defeats the goal of using condoms. ... for the FPA, Family Planning association, and the findings revealed ... reasons for ineffective use of condoms. As much as 43% ...
... the US U.S. doctors often misdiagnose tuberculosis due to ... suffer for years.// ,Tuberculosis is among the ... to the World Health Organization, has taken the lives ... tuberculosis bacterium has the ability to remain dormant for ...
... air sterilization technology that the U.S. Department of Defense ... may be protecting hospital patients from deadly infections, thanks ... of Science, Technology and Academic Research (NYSTAR). ,The ... becoming increasingly difficult to treat, are on the rise. ...
... known; a bite on the body that allows the virus ... happens next that causes the virus //to multiply and take ... Medical Institute (HHMI) international scholar in Argentina have been able ... virus multiply, which is the main cause of the potentially ...
... by the stem cells researchers across the world and ... Illumina Inc., it was found that embryonic stem cell ... totipotent. ,This sets aside the embryonic stem ... These characteristics could be later used to replace diseased ...
... Treatment Trial (NETT) it was found that emphysema patients ... ,The bilateral lung volume reduction surgery (LVRS) to ... among these patients. NETT researchers describe the effects of ... 4.3 years, two years longer than the primary results ...
Cached Medicine News:Health News:Doctors In US Lack Skills For The Diagnosis Of TB 2Health News:Device Can "Battle" Hospital Infections 2Health News:Device Can "Battle" Hospital Infections 3Health News:The Dengue Virus Unplugged 2Health News:The Dengue Virus Unplugged 3Health News:Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning 2
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
... Mid-Urethral Sling System is intended to ... sling for the treatment of stress ... an innovative mid-urethral sling that offers ... all of which are designed to ...
Medicine Products: